results of a phase i study of sonrotoclax for the treatment of r/r waldenström’s macroglobulinemia
Published 1 month ago • 90 plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
2:25
results from a phase i/ii trial of pirtobrutinib and lv20.19 for patients with r/r lymphomas
-
4:58
findings of a phase i study of anitocabtagene autoleucel for the treatment of r/r myeloma
-
2:42
results from a phase i study of cc-98633 in r/r myeloma
-
1:30
a phase i trial of voruciclib /- venetoclax for the treatment of nhl and aml
-
1:42
treating cll after venetoclax or btk inhibitors
-
5:15
day in the life - heamatology / research - prof john rasko
-
24:46
sumit verma of iovance biotherapeutics - 1 time therapy for solid tumors
-
2:19
anbal-cel: updated results from phase i study of novel cd19-targeting car-t therapy
-
2:12
results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
-
4:13
benefit trial: isatuximab, lenalidomide, and dexamethasone /- bortezomib in newly diagnosed myeloma
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
1:56
updated results of phase i/ii bruin study: pirtobrutinib in covalent btk inhibitor pretreated mcl
-
5:32
carbon: results of phase i study of ctx110 allogeneic crispr-cas9-engineered car-ts in r/r lbcl
-
2:58
results of a phase ib study of ibrutinib obinutuzumab in r/r cll
-
2:03
preliminary results of a phase ii study of fedratinib in patients with mds/mpn and cnl
-
1:52
evaluating the efficacy of obinutuzumab, ibrutinib, and venetoclax in richter's transformation
-
1:40
results from a phase i/ii study of golcadomide in r/r follicular lymphoma
-
2:04
introducing a phase ib/ii trial to evaluate tasquinimod for the treatment of myelofibrosis
-
1:31
pembrolizumab plus avd in chl: long-term follow-up of a phase ii study
-
2:07
phase i/ii study of edit-301, a novel gene-edited autologous hsc medicine, in patients with scd
-
3:56
results of the phase ii titan study of caplacizumab in patients with attp